Member Info for potnak

Joking aside though. The interims are just regulatory. Nothing will be released to cause any excitement. Why they were delayed is still a mystery and I'm not sure we'll get an answer either.

No, this is a look who got on our board. When an RNS states the sales of other drugs, the company is more interested in the money rather than the science. Might be good for short term trading but long term investing is out if there isn't a vision.

Seems a strange appointment when they're only just starting on the long road to market. There is potential here but this is an exercise in PR more than anything else. Still at least 5 years before they get a sniff of profits.

Agreed, that's what the board for, share discussion. But.. they can't release news if there isn't any news or if their hands are tied because on an NDA. The issue with share boards is everyone gets caught up in the hype then when it doesn't happen they blame the company for it. SAR doesn't hype and they aren't leaky so we know everything that the regulations state we should. 6 million is a decent amount of shares Aber, are you in profit?

Exactly Ahfam3. I don't get it. Unless you are going to sell at 1.5p or something. What does it matter? We haven't had any bad news yet, it is all good. I've always thought my investment here will last until 2019, my target is still 3 - 5p. Could it happen sooner, absolutely! Could we get more than 5p, absolutely! If we get to this time next year and nothing significant has happened. I will start to look for a way out. My biggest fear is they park Aurora, IMO, I don't think it's going anywhere but if they did park it. The market would punish us and I think we'd drop back to circa 0.5p

Nope. Think it was everyone but Parker.

If you want to to invest in CHK1. Invest in SRRA. Its as simple as that we're in a position where we have little risk and no financial obligations fir CHK1. Which is exactly what the business model of Sar is. We develop compounds, license them, then someone else takes it to market I don't have an issue with this.

What a difference a week makes. This time last week this board was full of optimistic posts. Now, after a really good update on one of our compounds everyone is super negative. I said that this update wouldn't affect the sp much and it didn't. Our interims won't do anything either. The only thing that will get the sp moving is a deal, something tangible, money in the bank. If you can accept all this, it's a lot easier to just sit and wait. I wouldnt mind betting that Sar have an NDA with o e of the big pharmas already.and Parker will be a hero if that's the case. Its just a matter of time.

First part of my prediction (guess)! Boom!

Also, I can't actually believe that a storming PI, starting PIIa and expanding beyond the planned PII trials doesn't constitute 'certain development milestones'.

Yes, I did mean CRT. This is the worst thing about SAR. You always have to read between the lines. If they are waiting for something, it must be financial\price sensitive otherwise, why wait?

I think we will be getting a milestone RNS. My complete guess is Sierra to fundraise to pay for the new trials then they will notify the market that they are paying milestones to SRI which will trigger an RNS from us. Then the Interims will be released. The reason we have to wait is we are bottom of the pile.

Luton - That's what I believe will happen. If that is the plan then it would explain why SAR only put the minimum amount of news out.

Yep, all good where I am looking. Just think we'll be bought out before PIII. Think we'll be too expensive after that point.

It's my belief that the the long term strategy is to sell the lot. I don't believe we'll ever see royalties from any of the compounds. Anything over 10p will do.

Why did a €500k deal take the market cap to 20 million? There is no explanation but that won't stop people selling here to chase the next rainbow.

I don't think anyone is being negative, i'm certainly not. I have 2.5 million shares here and i'm in profit. Some here have much much more and are in profit. We know it's a long game that's all and the likes of a �20 mil deal would only see the SP at 2p. Firms like PYC would 100 bag on a similar deal.

I said that answering the original post asking why people were selling. SAR won't multi-bag until we have a deal that multiplies the MC several times. Companies like PYC, VAL, HEMO and dozens of others may multi-bag on an old fiver, sentiment and unicorn spit. That's why people are selling.

PYC held around 25p long enough to get out though. It seems there were plenty of long-term holders who didn't take the opportunity to do so. They had the chance to get out at around 19p and 12p respectively too.

I don't really care if the SP goes up or not, its a moot point because IMO this will go up in a straight line when news of licensing deals or TO comes. LIke TM says, the time will come when we will have a deal on the table that is multiples of the current MC.